Skip to main content
Erschienen in: Journal of Cancer Survivorship 2/2017

16.11.2016

Cardiovascular disease and physical activity in adult cancer survivors: a nested, retrospective study from the Atlantic PATH cohort

verfasst von: Melanie R. Keats, Yunsong Cui, Scott A. Grandy, Louise Parker

Erschienen in: Journal of Cancer Survivorship | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The study aimed to examine the relationship between cardiovascular disease (CVD) and physical activity (PA) levels in cancer survivors (CS).

Methods

Using a nested, retrospective follow-up design, this study presents the self-reported prevalence of CVD in an Atlantic Canadian population-based cohort of 1526 CS and 6034 age-sex matched, non-cancer controls ranging from 35 to 69 years of age. Univariate and multiple logistic regression models were used to explore the association between CVD and PA.

Results

Overall, CS were 30% more likely to have ever experienced a CVD event than controls (OR = 1.3; 95% CI 1–1.7, p = .07). Survivors were also significantly more likely to report having hypertension (OR = 1.60; 95% CI 1.03–1.3, p = .02) and diabetes (OR = 1.27; 95% CI 1.03–1.16, p = .02). Compared to controls, CS were significantly less likely to engage in high levels of PA. For survivors, compared to those who were least physically active, the odds of having a CVD risk factor was 35% lower for those who were moderately active (OR = 0.65; 95% CI 0.48–0.88) and 45% lower in the most highly active group (OR = 0.55; 95% CI 0.4–0.73). For controls, the odds of having a CVD risk factor was 25% lower for those in the moderately active group (OR = 0.75; 95% CI 0.64–0.88) and 30% lower for those in the high active group (OR = 0.70; 95% CI 0.6–0.81).

Conclusion

Low active survivors appear to be at a high risk of CVD-related comorbidity.

Implications for cancer survivors

PA is associated with lower CVD-related comorbidity in CS, suggesting that interventions directed at increasing PA should be implemented to improve long-term health outcomes.
Literatur
1.
Zurück zum Zitat DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics. CA Cancer J Clin. 2014;64(4):252–71.CrossRefPubMed DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics. CA Cancer J Clin. 2014;64(4):252–71.CrossRefPubMed
2.
Zurück zum Zitat Demark-Wahnefried W, Aziz NM, Rowland JH, et al. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol. 2005;23(24):5814–30.CrossRefPubMedPubMedCentral Demark-Wahnefried W, Aziz NM, Rowland JH, et al. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol. 2005;23(24):5814–30.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Eakin EG, Youlden DR, Baade PD, et al. Health status of long-term cancer survivors: results from an Australian population-based sample. Cancer Epidemiol Biomark Prev. 2006;15(10):1969–76.CrossRef Eakin EG, Youlden DR, Baade PD, et al. Health status of long-term cancer survivors: results from an Australian population-based sample. Cancer Epidemiol Biomark Prev. 2006;15(10):1969–76.CrossRef
4.
Zurück zum Zitat Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci 2003;58(1):82–91.CrossRefPubMed Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci 2003;58(1):82–91.CrossRefPubMed
5.
Zurück zum Zitat Baade PD, Fritschi L, Eakin EG. Non-cancer mortality among people diagnosed with cancer (Australia). Cancer Causes Control. 2006;17(3):287–97.CrossRefPubMed Baade PD, Fritschi L, Eakin EG. Non-cancer mortality among people diagnosed with cancer (Australia). Cancer Causes Control. 2006;17(3):287–97.CrossRefPubMed
6.
7.
Zurück zum Zitat Patnaik JL, Byers T, DiGuiseppi C, et al. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011;13(3):R64.CrossRefPubMedPubMedCentral Patnaik JL, Byers T, DiGuiseppi C, et al. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011;13(3):R64.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Chow EJ, Mueller BA, Baker KS, et al. Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation. Ann Intern Med. 2011;155(1):21–32.CrossRefPubMed Chow EJ, Mueller BA, Baker KS, et al. Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation. Ann Intern Med. 2011;155(1):21–32.CrossRefPubMed
9.
Zurück zum Zitat Al-Kindi SG, Abu-Zeinah GF, Kim CH, et al. Trends and disparities in cardiovascular mortality among survivors of Hodgkin lymphoma. Clin Lymphoma Myeloma Leuk. 2015;15(12):748–52.CrossRefPubMed Al-Kindi SG, Abu-Zeinah GF, Kim CH, et al. Trends and disparities in cardiovascular mortality among survivors of Hodgkin lymphoma. Clin Lymphoma Myeloma Leuk. 2015;15(12):748–52.CrossRefPubMed
10.
Zurück zum Zitat Armenian SH, Chow EJ. Cardiovascular disease in survivors of hematopoietic cell transplantation. Cancer. 2014;120(4):469–79.CrossRefPubMed Armenian SH, Chow EJ. Cardiovascular disease in survivors of hematopoietic cell transplantation. Cancer. 2014;120(4):469–79.CrossRefPubMed
11.
Zurück zum Zitat Armenian SH, Xu L, Ky B, et al. Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study. J Clin Oncol. 2015; doi:10.1200/JCO.2015.64.0409. Armenian SH, Xu L, Ky B, et al. Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study. J Clin Oncol. 2015; doi:10.​1200/​JCO.​2015.​64.​0409.
12.
Zurück zum Zitat Kreatsoulas C, Subramanian SV. An emerging double burden of disease: the prevalence of individuals with cardiovascular disease and cancer. J Intern Med. 2013;275:494–504.CrossRefPubMed Kreatsoulas C, Subramanian SV. An emerging double burden of disease: the prevalence of individuals with cardiovascular disease and cancer. J Intern Med. 2013;275:494–504.CrossRefPubMed
13.
Zurück zum Zitat Janssen-Heijnen MLG, Szerensci K, van de Schans SAM, Maas HAAM, Widdershoven JW, Coebergh JWW. Cancer patients with cardiovascular disease have survival rates to cancer patients within the age-cohort of 10 years older without cardiovascular morbidity. Crit Rev Oncol Hematol. 2010;76:196–207.CrossRefPubMed Janssen-Heijnen MLG, Szerensci K, van de Schans SAM, Maas HAAM, Widdershoven JW, Coebergh JWW. Cancer patients with cardiovascular disease have survival rates to cancer patients within the age-cohort of 10 years older without cardiovascular morbidity. Crit Rev Oncol Hematol. 2010;76:196–207.CrossRefPubMed
14.
15.
Zurück zum Zitat O'Hare M, Sharma A, Murphy K, et al. Cardio-oncology part I: chemotherapy and cardiovascular toxicity. Expert Rev Cardiovasc Ther. 2015;13(5):511–8.CrossRefPubMed O'Hare M, Sharma A, Murphy K, et al. Cardio-oncology part I: chemotherapy and cardiovascular toxicity. Expert Rev Cardiovasc Ther. 2015;13(5):511–8.CrossRefPubMed
16.
Zurück zum Zitat Rosa GM, Gigli L, Tagliasacchi MI, et al. Update on cardiotoxicity of anti-cancer treatments. Eur J Clin Investig. 2016;46(3):264–84.CrossRef Rosa GM, Gigli L, Tagliasacchi MI, et al. Update on cardiotoxicity of anti-cancer treatments. Eur J Clin Investig. 2016;46(3):264–84.CrossRef
17.
Zurück zum Zitat Jones LW, Haykowsky MJ, Swartz JJ. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol. 2007;50(15):1435–41.CrossRefPubMed Jones LW, Haykowsky MJ, Swartz JJ. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol. 2007;50(15):1435–41.CrossRefPubMed
18.
Zurück zum Zitat Sallis R. Exercise is medicine: a call to action for physicians to assess and prescribe exercise. Phys Sportsmed. 2015;43(1):22–6.CrossRefPubMed Sallis R. Exercise is medicine: a call to action for physicians to assess and prescribe exercise. Phys Sportsmed. 2015;43(1):22–6.CrossRefPubMed
20.
Zurück zum Zitat Li T, Wei S, Shi Y, et al. The dose-response effect of physical activity on cancer mortality: findings from 71 prospective cohort studies. Br J Sports Med. 2016;50(6):339–45.CrossRefPubMed Li T, Wei S, Shi Y, et al. The dose-response effect of physical activity on cancer mortality: findings from 71 prospective cohort studies. Br J Sports Med. 2016;50(6):339–45.CrossRefPubMed
21.
Zurück zum Zitat Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39(8):1423–34.CrossRefPubMed Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39(8):1423–34.CrossRefPubMed
22.
Zurück zum Zitat Scott JM, Armenian S, Giralt S, et al. Cardiovascular disease following hematopoietic stem cell transplantation: pathogenesis, detection, and the cardioprotective role of aerobic training. Crit Rev Oncol Hematol. 2016;98:222–34.CrossRefPubMed Scott JM, Armenian S, Giralt S, et al. Cardiovascular disease following hematopoietic stem cell transplantation: pathogenesis, detection, and the cardioprotective role of aerobic training. Crit Rev Oncol Hematol. 2016;98:222–34.CrossRefPubMed
23.
Zurück zum Zitat Scott JM, Lakoski S, Mackey JR, et al. The potential role of aerobic exercise to modulate cardiotoxicity of molecularly targeted cancer therapeutics. Oncologist. 2013;18(2):221–31.CrossRefPubMedPubMedCentral Scott JM, Lakoski S, Mackey JR, et al. The potential role of aerobic exercise to modulate cardiotoxicity of molecularly targeted cancer therapeutics. Oncologist. 2013;18(2):221–31.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Borugian MJ, Robson P, Fortier I, et al. The Canadian Partnership for Tomorrow Project: building a pan-Canadian research platform for disease prevention. CMAJ. 2010;182(11):1197–201.CrossRefPubMedPubMedCentral Borugian MJ, Robson P, Fortier I, et al. The Canadian Partnership for Tomorrow Project: building a pan-Canadian research platform for disease prevention. CMAJ. 2010;182(11):1197–201.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–95.CrossRefPubMed Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–95.CrossRefPubMed
27.
Zurück zum Zitat Chau JY, Grunseit A, Midthjell K, et al. Sedentary behaviour and risk of mortality from all-causes and cardiometabolic diseases in adults: evidence from the HUNT3 population cohort. Br J Sports Med. 2015;49(11):737–42.CrossRefPubMed Chau JY, Grunseit A, Midthjell K, et al. Sedentary behaviour and risk of mortality from all-causes and cardiometabolic diseases in adults: evidence from the HUNT3 population cohort. Br J Sports Med. 2015;49(11):737–42.CrossRefPubMed
29.
Zurück zum Zitat Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–52.CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–52.CrossRefPubMed
30.
Zurück zum Zitat D'Agostino Sr RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–53.CrossRefPubMed D'Agostino Sr RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–53.CrossRefPubMed
31.
Zurück zum Zitat Wilkins K, Campbell NR, Joffres MR, et al. Blood pressure in Canadian adults. Health Rep. 2010;21(1):37–46.PubMed Wilkins K, Campbell NR, Joffres MR, et al. Blood pressure in Canadian adults. Health Rep. 2010;21(1):37–46.PubMed
33.
Zurück zum Zitat Daher IN, Daigle TR, Bhatia N, et al. The prevention of cardiovascular disease in cancer survivors. Tex Heart Inst J. 2012;39(2):190–8.PubMedPubMedCentral Daher IN, Daigle TR, Bhatia N, et al. The prevention of cardiovascular disease in cancer survivors. Tex Heart Inst J. 2012;39(2):190–8.PubMedPubMedCentral
34.
Zurück zum Zitat Weaver KE, Foraker RE, Alfano CM, et al. Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv. 2013;7(2):253–61.CrossRefPubMedPubMedCentral Weaver KE, Foraker RE, Alfano CM, et al. Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv. 2013;7(2):253–61.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Curigliano G, Cardinale D, Dent S, et al. Cardiotoxicity of anticancer treatments: epidemiology, detection, and management. CA Cancer J Clin. 2016; doi:10.3322/caac.21341.PubMed Curigliano G, Cardinale D, Dent S, et al. Cardiotoxicity of anticancer treatments: epidemiology, detection, and management. CA Cancer J Clin. 2016; doi:10.​3322/​caac.​21341.PubMed
36.
Zurück zum Zitat Knobf MT, Coviello J. Lifestyle interventions for cardiovascular risk reduction in women with breast cancer. Curr Cardiol Rev. 2011;7(4):250–7.CrossRefPubMed Knobf MT, Coviello J. Lifestyle interventions for cardiovascular risk reduction in women with breast cancer. Curr Cardiol Rev. 2011;7(4):250–7.CrossRefPubMed
37.
Zurück zum Zitat Søgaard M, Thomsen RW, Bossen KS, et al. The impact of comorbidity on cancer survival: a review. Clin Epidemiol. 2014;5(Suppl 1):3–29. Søgaard M, Thomsen RW, Bossen KS, et al. The impact of comorbidity on cancer survival: a review. Clin Epidemiol. 2014;5(Suppl 1):3–29.
38.
Zurück zum Zitat Patnaik JL, Byers T, Diguiseppi C, et al. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst. 2011;103(14):1101–11.CrossRefPubMedPubMedCentral Patnaik JL, Byers T, Diguiseppi C, et al. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst. 2011;103(14):1101–11.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Kirkham AA, Bland KA, Sayyari S, et al. Clinically relevant physical benefits of exercise interventions in breast cancer survivors. Curr Oncol Rep. 2016;18(2):12.CrossRefPubMed Kirkham AA, Bland KA, Sayyari S, et al. Clinically relevant physical benefits of exercise interventions in breast cancer survivors. Curr Oncol Rep. 2016;18(2):12.CrossRefPubMed
41.
Zurück zum Zitat Adams SA, Matthews CE, Ebbeling CB, et al. The effect of social desirability and social approval on self-reports of physical activity. Am J Epidemiol. 2005;161(4):389–98.CrossRefPubMedPubMedCentral Adams SA, Matthews CE, Ebbeling CB, et al. The effect of social desirability and social approval on self-reports of physical activity. Am J Epidemiol. 2005;161(4):389–98.CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Prince SA, Adamo KB, Hamel ME, et al. A comparison of direct versus self-report measures for assessing physical activity in adults: a systematic review. Int J Behav Nutr Phys Act. 2008;5:56.CrossRefPubMedPubMedCentral Prince SA, Adamo KB, Hamel ME, et al. A comparison of direct versus self-report measures for assessing physical activity in adults: a systematic review. Int J Behav Nutr Phys Act. 2008;5:56.CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Schmitz KH, Courneya KS, Matthews C, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409–26.CrossRefPubMed Schmitz KH, Courneya KS, Matthews C, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409–26.CrossRefPubMed
44.
Zurück zum Zitat Keogh J, Olsen A, Climstein M, Sargeant S, Jones L. Benefits and barriers of cancer practitioners discussing physical activity with their cancer patients. J Canc Educ. 2015. Keogh J, Olsen A, Climstein M, Sargeant S, Jones L. Benefits and barriers of cancer practitioners discussing physical activity with their cancer patients. J Canc Educ. 2015.
45.
Zurück zum Zitat Santa Mina D, Alibhai SM, Matthew AG, et al. Exercise in clinical cancer care: a call to action and program development description. Curr Oncol. 2012;19(3):e136–44.CrossRefPubMedPubMedCentral Santa Mina D, Alibhai SM, Matthew AG, et al. Exercise in clinical cancer care: a call to action and program development description. Curr Oncol. 2012;19(3):e136–44.CrossRefPubMedPubMedCentral
Metadaten
Titel
Cardiovascular disease and physical activity in adult cancer survivors: a nested, retrospective study from the Atlantic PATH cohort
verfasst von
Melanie R. Keats
Yunsong Cui
Scott A. Grandy
Louise Parker
Publikationsdatum
16.11.2016
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 2/2017
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-016-0584-x

Weitere Artikel der Ausgabe 2/2017

Journal of Cancer Survivorship 2/2017 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.